Jupiter Neurosciences, Inc. (JUNS) delivered a return of -77.61% over the past year. Since JUNS does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Jupiter Neurosciences, Inc. one year ago would be worth $2,239 today, representing a loss of $7,761.

Jupiter Neurosciences, Inc. (JUNS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For JUNS, the total return equals the price-only return.

No, Jupiter Neurosciences, Inc. (JUNS) underperformed the S&P 500 by 98.45 percentage points over the past year. JUNS delivered a total return of -77.61%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed JUNS by 98.45pp during this period.

Jupiter Neurosciences, Inc. (JUNS) experienced a maximum drawdown of -93.44% over the past year, declining from its peak on 2025-07-15 to its trough on 2026-05-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Jupiter Neurosciences, Inc. (JUNS)'s long-term returns with dividends reinvested. Over 10 years, the total return is -95.4% (-26.5% CAGR) — $10,000 would have grown to $461. Over 20 years: -95.4% total return (-14.3% CAGR) — $10,000 → $461. Over 30 years: -95.4% total return (-9.7% CAGR) — $10,000 → $461. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Jupiter Neurosciences, Inc.'s best calendar year was 2024 with a total return of 94.9%. Its worst year was 2025 with a total return of -90.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 185.2 percentage points.